©The Author(s) 2022.
World J Gastroenterol. Jul 28, 2022; 28(28): 3720-3731
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3720
Published online Jul 28, 2022. doi: 10.3748/wjg.v28.i28.3720
Table 3 Top 10 related funding agencies in Clostridium difficile-associated diarrhea between 2001 and 2020
| Position | Funding agencies | Country | No. of publication | % |
| 1st | National Institutes of Health | United States | 884 | 10.88 |
| 2nd | U.S. Department of Health and Human Services | United States | 841 | 10.35 |
| 3rd | National Institute of Allergy and Infectious Diseases | United States | 539 | 6.63 |
| 4th | National Institute of Diabetes and Digestive and Kidney Diseases | United States | 239 | 2.94 |
| 5th | Merck | United States | 171 | 2.10 |
| 6th | National Center for Advancing Translational Sciences | United States | 154 | 1.89 |
| 7th | Medical Research Council | United Kingdom | 150 | 1.85 |
| 8th | National Institute of General Medical Sciences | United States | 146 | 1.80 |
| 9th | Pfizer | United States | 137 | 1.69 |
| 10th | United Kingdom Research and Innovation | United Kingdom | 132 | 1.62 |
- Citation: Zyoud SH. Global research on Clostridium difficile-associated diarrhoea: A visualized study. World J Gastroenterol 2022; 28(28): 3720-3731
- URL: https://www.wjgnet.com/1007-9327/full/v28/i28/3720.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i28.3720